IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Protagonist Therapeutics Inc

CUSIP: 074366E10 | 2 institutional holders

Quarters

Q4 2023Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

Schroder Investment Management Group19,900
0.0% of portfolio›$456.3K
StyleTurnoverLocationFiled
Schroder Investment Management Group
19,900$456.3K0.0%CoreMediumLondon, United Kingdom2024-02-14